Abstract
Clinical and histologic effects of topical recombinant α-interferon (IFN), systemic IFN, topical dexamethasone, and dexamethasone plus topical IFN on corneal neovascularization in response to silver nitrate cauterization were investigated in 110 eyes of 60 Wistar rats. The eyes were evaluated according to the burn stimulus, neovascularization, and histologic inflammation grades 5 days after cauterization. Antineovascular effects of topical and systemic IFN were significantly greater than a placebo but less than dexamethasone alone or in combination with IFN.
Similar content being viewed by others
References
Hoban BP, Collin HB. Effects of salicylate and steroid on neutrophil migration and corneal blood vessel growth. Am J Optom Physiol Optics. 1986;63:271–276.
Former CH, Klintworth GK. An evaluation of the role of leukocytes in the pathogenesis of experimentally induced corneal vascularization. Am J Pathol. 1975;79:537–550.
Former CH, Klintworth GK. An evaluation of the role of leukocytes in the pathogenesis of experimentally induced corneal vascularization. Am J Pathol. 1975;81:531–544.
Former CH, Klintworth GK. An evaluation of the role of leukocytes in the pathogenesis of experimentally induced corneal vascularization. Am J Pathol. 1976;82:157–170.
Mahoney JM, Waterbury LD. Drug effects on the neovascularization response to silver nitrate cauterization of the rat cornea. Curr Eye Res. 1985;4:531–535.
Cooper CA, Micheal MD, Bergamini VW, Leopold IH. Use of flubiprofen to inhibit corneal neovascularization. Arch Ophthalmol. 1980;98:1102–1105.
Phillips K, Arffa R, Cintron C, et al. Effects of prednisolone and medroxyprogesterone on corneal wound healing, ulceration and neovascularization. Arch Ophthalmol. 1983;101:640–643.
Einhorn S, Blomgren H, Cantell K, Strander H. In vivo administration of interferon to man: studies on the immune system. Ann NY Acad Sci. 1980;350:580–582.
Boye DB, Zetter BR. Inhibition of cell motility by interferon. Science. 1980;208:516–518.
Saiki I, Dunegan MA, Fann AV, Koff WC. Regulatory effects on macrophages of human recombinant interferons. J Interferom Res. 1986;6:603–611.
Johnson HM, Smith BG, Baron S. Inhibition of the primary in vitro antibody by interferon preparations. J Immunol. 1975;114:403–407.
Maeyer JD, Maeyer ED. Electrophoretically pure mouse interferon exerts multiple biological effects. Ann NY Acad Sci. 1980;350:347–353.
Miller JW, Stinson WG, Folkman J. Regression of experimental iris neovascularization with systemic alpha-interferon. Ophthalmology. 1993;100:9–14.
Merigan TC. Human interferon as a therapeutic agent. N Engl J Med. 1988;18:1458–1460.
Folkman J, Klagsburn M. Angiogenic factors. Science. 1987;235:442–447.
Suttorp SA, Cardozo N, Breedaart C, Kijlstra A. The fate of antigen-antibody complexes in the rabbit cornea. Curr Eye Res. 1991; 8:773–778.
Brodeur BR, Merigan TC. Suppressive effect of interferon on the humoral immune response to sheep red blood cells in mice. J Immunol. 1974;113:1319–1325.
Baron S, Tyring SK, Fleischmann R, et al. The interferons: mechanisms of action and clinical applications. JAMA. 1991;266:1375–1383.
Grasser L, Maroger LM, Jeans YD, Guillon V, Tovey G. Interferon-induced disease in mice and rats. Ann NY Acad Sci. 1980;350:12–20.
Sidky YA, Borden EC. Inhibition of angiogenesis by interferons: effects on tumor- and lymphocyte-induced vascular responses. Cancer Res. 1987;47:5155–5161.
White CW, Sondheimer HM, Crouch EC. Treatment of pulmonary heman giomatosis with recombinant interferon alpha-2a. N Engl J Med. 1989;320:1197–1200.
Chan CK, Kempin SJ, Noble SK, Palmer GA. The treatment of choroidal neovascular membranes by alpha interferon. Ophthalmology 1994;101:289–300.
Park WC, Shin DH. Regression of experimental corneal vascularization with subconjunctival injection of interferon α-2a. Invest Ophthalmol Vis Sci. 1994;35:1351.
Nguyen N, Goldberg M, Pico J, Kim W, Abbot RL, Levy B. Topical and subcutaneous alpha-interferon falls to suppress corneal neovascularization. Cornea. 1995;14:147–151.
Pharmacological Therapy for Macular Degeneration Study Group. Interferon alpha-2a is ineffective for patients with choroidal neovascularization secondary to age-related macular degeneration. Arch Ophthalmol. 1997;115:865–872.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Öztürk, F., Sobaci, G., Sami Ilker, S. et al. Antineovascular effect of α-interferon on corneal neovascularization in rats. Ann Ophthalmol 33, 35–39 (2001). https://doi.org/10.1007/s12009-001-0070-5
Issue Date:
DOI: https://doi.org/10.1007/s12009-001-0070-5